Is Mustang Bio Stock a Good Investment?
Mustang Bio Investment Advice | MBIO |
- Examine Mustang Bio's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Mustang Bio's leadership team and their track record. Good management can help Mustang Bio navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Mustang Bio's business and its evolving consumer preferences.
- Compare Mustang Bio's performance and market position to its competitors. Analyze how Mustang Bio is positioned in terms of product offerings, innovation, and market share.
- Check if Mustang Bio pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Mustang Bio's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Mustang Bio stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Mustang Bio is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Mustang Bio Stock
Researching Mustang Bio's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book ratio of 1.29. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mustang Bio recorded a loss per share of 13.81. The entity had not issued any dividends in recent years. The firm had 1:50 split on the 16th of January 2025.
To determine if Mustang Bio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Mustang Bio's research are outlined below:
| Mustang Bio generated a negative expected return over the last 90 days | |
| Mustang Bio has some characteristics of a very speculative penny stock | |
| Mustang Bio has high historical volatility and very poor performance | |
| Mustang Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (15.75 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Mustang Bio currently holds about 107.37 M in cash with (11.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01. |
Mustang Bio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Mustang Bio. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Mustang Bio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Mustang Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Mustang Bio's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-11-14 | 2022-09-30 | -0.2 | -0.18 | 0.02 | 10 | ||
2022-05-12 | 2022-03-31 | -0.18 | -0.2 | -0.02 | 11 | ||
2022-03-23 | 2021-12-31 | -0.19 | -0.22 | -0.03 | 15 | ||
2021-08-16 | 2021-06-30 | -0.2 | -0.16 | 0.04 | 20 | ||
2019-08-09 | 2019-06-30 | -0.25 | -0.29 | -0.04 | 16 | ||
2020-08-10 | 2020-06-30 | -0.27 | -0.32 | -0.05 | 18 | ||
2018-08-13 | 2018-06-30 | -0.25 | -0.19 | 0.06 | 24 | ||
2018-11-13 | 2018-09-30 | -0.2 | -0.28 | -0.08 | 40 |
Know Mustang Bio's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Mustang Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mustang Bio backward and forwards among themselves. Mustang Bio's institutional investor refers to the entity that pools money to purchase Mustang Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Activest Wealth Management | 2025-03-31 | 2.0 | Group One Trading, Lp | 2025-03-31 | 1.0 | Susquehanna International Group, Llp | 2024-12-31 | 0.0 | Hightower Advisors, Llc | 2024-12-31 | 0.0 | Northern Trust Investments N A | 2024-12-31 | 0.0 | Jamison Private Wealth Management Inc | 2024-12-31 | 0.0 | Citadel Advisors Llc | 2024-12-31 | 0.0 | Jump Financial Llc | 2024-12-31 | 0.0 | Koss-olinger Consulting, Llc | 2024-12-31 | 0.0 | Anson Funds Management Lp | 2025-03-31 | 45.7 K | Geode Capital Management, Llc | 2025-03-31 | 15.8 K |
Mustang Bio's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.6 M.Market Cap |
|
Mustang Bio's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.69) | (1.78) | |
| Return On Capital Employed | 4.92 | 5.17 | |
| Return On Assets | (1.69) | (1.78) | |
| Return On Equity | 4.07 | 4.27 |
Determining Mustang Bio's profitability involves analyzing its financial statements and using various financial metrics to determine if Mustang Bio is a good buy. For example, gross profit margin measures Mustang Bio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Mustang Bio's profitability and make more informed investment decisions.
Evaluate Mustang Bio's management efficiency
Mustang Bio has return on total asset (ROA) of (0.321) % which means that it has lost $0.321 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.9131) %, meaning that it created substantial loss on money invested by shareholders. Mustang Bio's management efficiency ratios could be used to measure how well Mustang Bio manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Mustang Bio's Return On Capital Employed is very stable compared to the past year. As of the 22nd of June 2025, Return On Equity is likely to grow to 4.27, while Return On Tangible Assets are likely to drop (1.78). At this time, Mustang Bio's Net Tangible Assets are very stable compared to the past year. As of the 22nd of June 2025, Non Currrent Assets Other is likely to grow to about 333.4 K, while Total Assets are likely to drop about 8.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.63) | (0.60) | |
| Tangible Book Value Per Share | (0.63) | (0.60) | |
| Enterprise Value Over EBITDA | (2.97) | (3.12) | |
| Price Book Value Ratio | (14.00) | (13.30) | |
| Enterprise Value Multiple | (2.97) | (3.12) | |
| Price Fair Value | (14.00) | (13.30) | |
| Enterprise Value | 55.5 M | 52.7 M |
The operational strategies employed by Mustang Bio management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Beta 2.245 |
Basic technical analysis of Mustang Stock
As of the 22nd of June, Mustang Bio secures the Risk Adjusted Performance of (0.13), mean deviation of 3.22, and Standard Deviation of 4.37. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mustang Bio, as well as the relationship between them.Mustang Bio's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mustang Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mustang Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Mustang Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Understand Mustang Bio's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Mustang Bio's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.13) | |||
| Market Risk Adjusted Performance | (0.36) | |||
| Mean Deviation | 3.22 | |||
| Coefficient Of Variation | (1,172) | |||
| Standard Deviation | 4.37 | |||
| Variance | 19.12 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.45) | |||
| Treynor Ratio | (0.37) | |||
| Maximum Drawdown | 21.35 | |||
| Value At Risk | (7.52) | |||
| Potential Upside | 7.26 | |||
| Skewness | 0.3448 | |||
| Kurtosis | 0.4514 |
| Risk Adjusted Performance | (0.13) | |||
| Market Risk Adjusted Performance | (0.36) | |||
| Mean Deviation | 3.22 | |||
| Coefficient Of Variation | (1,172) | |||
| Standard Deviation | 4.37 | |||
| Variance | 19.12 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.45) | |||
| Treynor Ratio | (0.37) | |||
| Maximum Drawdown | 21.35 | |||
| Value At Risk | (7.52) | |||
| Potential Upside | 7.26 | |||
| Skewness | 0.3448 | |||
| Kurtosis | 0.4514 |
Consider Mustang Bio's intraday indicators
Mustang Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mustang Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Mustang Bio time-series forecasting models is one of many Mustang Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mustang Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Mustang Stock media impact
There is far too much social signal, news, headlines, and media speculation about Mustang Bio that are available to investors today. This information is accessible both publicly - through Mustang Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Mustang-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Mustang Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Mustang Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Mustang Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Mustang Bio alpha.
Mustang Bio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Mustang Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Mustang Bio Corporate Management
| Kerry BBA | VP Operations | Profile | |
| Lynn MS | VP Affairs | Profile | |
| Eliot CPA | Interim Officer | Profile | |
| Richard MS | Head Development | Profile | |
| Matthew JD | VP Counsel | Profile | |
| Bruce MD | Senior Development | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Mustang Bio's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.